Breaking News

IPS Appoints Compliance Manager

July 15, 2013

Gilliam brings more than 25 years of experience

Elmer Gilliam, Jr. has been appointed regional compliance manager, Southern Region, at IPS-Integrated Project Services, Inc. Mr. Gilliam will be based out of the company’s NC office.
Mr. Gilliam has more than 25 years of experience in engineering, quality assurance and compliance for biopharmaceutical manufacturing facilities. His experience includes the development, implementation and management of Lean, Six Sigma programs and quality systems projects. Mr. Gilliam has led a variety of continuous improvement initiatives and has directed validation activities for capital projects with companies such as Talecris Biotherapeutics, Merck & Co. and Purdue Pharmaceuticals.
“We are pleased to welcome Elmer to IPS,” said Dave Goswami, PE, chairman and chief executive officer, IPS. “Elmer’s demonstrated leadership in validation project management, operational excellence, continuous improvement and quality assurances are tremendous assets for IPS, and will prove valuable to our clients as well.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important